Table 2 CFUs of the control (untreated culture), after being in contact with the respective solutions (SDF, PI and SF + PI) and reduction rates in percent achieved by the respective antibacterial solutions
Trial | Control | SDF | SDF (%) | PI | PI (%) | SDF + PI | SF + PI (%) |
|---|---|---|---|---|---|---|---|
Enterococcus faecalis DSM 20376 | |||||||
Mean | 168.0 × 105 | 10.0 × 102 | 99.99 | 210.8 × 102 | 99.86 | 40.9 × 102 | 99.96 |
SD | 98.62 | 16.47 | 0.01 | 238.52 | 0.18 | 36.25 | 0.04 |
M | 141.5 × 105 | 1.75 × 102 | 99.99 | 98.5 × 102 | 99.93 | 35.3 × 102 | 99.98 |
Min | 83.0 × 105 | 0.0 | 99.97 | 29 × 102 | 99.51 | 1.6 × 102 | 99.89 |
Max | 353.0 × 105 | 41.5 × 102 | 99.99 | 604 × 102 | 99.98 | 84.8 × 102 | 99.99 |
Parvimonas micra DSM 20468 | |||||||
Mean | 32.2 × 105 | 0.0 | 100.00 | 37.9 × 102 | 99.98 | 0.0 | 100.00 |
SD | 22.06 | 0.0 | 0.00 | 68.78 | 0.03 | 0.0 | 0.00 |
M | 26.4 × 105 | 0.0 | 100.00 | 2.8 × 102 | 99.99 | 0.0 | 100.00 |
Min | 5.2 × 105 | 0.0 | 100.00 | 0.0 | 99.93 | 0.0 | 100.00 |
Max | 66.0 × 105 | 0.0 | 100.00 | 173.0 × 102 | 100.00 | 0.0 | 100.00 |
Actinomyces naeslundii A65 | |||||||
Mean | 150.0 × 105 | 0.0 | 100.00 | 443.3 × 102 | 99.73 | 4.8 × 102 | 100.00 |
SD | 67.18 | 0.0 | 0.0 | 472.55 | 0.25 | 8.13 | 0.01 |
M | 138.0 × 105 | 0.0 | 100.00 | 274.5 × 102 | 99.78 | 0.0 | 100.00 |
Min | 71.0 × 106 | 0.0 | 100.00 | 50.0 × 102 | 99.27 | 0.0 | 99.98 |
Max | 269.0 × 106 | 0.0 | 100.00 | 1250.0 × 102 | 99.95 | 19.5 × 102 | 100.00 |